ERNAW
Financials
- Market Capitalization 7.068 M
- Employee 5
- Founded 2018
- CEO N/A
- Website www.ernexatx.com
- Headquarter Delaware, United States
- FIGI BBG000CX5677
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 5351 |  GRFS Grifols, S.A. - American Depositary Shares | 7.02 USD | -2.50% | -0.99% | -9.18% | -29.80% | 0 USD | ||
| 7350 |  SCLXW Scilex Holding Company - Warrant | 0.2075 USD | +6.57% | +1.22% | +9.21% | +116.15% | 74.38 M USD | ||
| 7452 |  MDCXW Medicus Pharma Ltd. - Warrant | 0.5100 USD | -3.77% | -28.17% | +41.63% | -27.14% | 20.40 M USD | ||
| 7500 |  LIMNW Liminatus Pharma, Inc. - Warrants | 0.0501 USD | 0.00% | -16.50% | -17.87% | -64.47% | 4.49 M USD |
Frequently asked questions about Ernexa Therapeutics Inc. - Warrants
What is the Ernexa Therapeutics Inc. - Warrants stock price today?
The current price of Ernexa Therapeutics Inc. - Warrants (ERNAW) is 0.11. Over the past 24 hours, the stock has changed by 0.00%. Follow the ERNAW chart for real-time price dynamics.
What is the stock ticker of Ernexa Therapeutics Inc. - Warrants?
Ernexa Therapeutics Inc. - Warrants trades under the ticker ERNAW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Ernexa Therapeutics Inc. - Warrants stock going up?
ERNAW has changed by +15.79% over the last week, -0.09% over the last month, and +10.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Ernexa Therapeutics Inc. - Warrants net income for the last quarter?
Ernexa Therapeutics Inc. - Warrants reported net income of -5.51 M for the last quarter. The previous quarter showed -1.5 M, which means net income changed by -266.33%.
How many employees does Ernexa Therapeutics Inc. - Warrants have?
As of the latest available data, Ernexa Therapeutics Inc. - Warrants has 5 employees. Workforce size can provide additional context about the company's scale and operations.
What is Ernexa Therapeutics Inc. - Warrants EBITDA?
Ernexa Therapeutics Inc. - Warrants EBITDA is -5.57 M, and its EBITDA margin is -39.77 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Ernexa Therapeutics Inc. - Warrants stock?
You can buy Ernexa Therapeutics Inc. - Warrants (ERNAW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Ernexa Therapeutics Inc. - Warrants stock?
Investing in Ernexa Therapeutics Inc. - Warrants requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ERNAW chart and related analysis on metatrader.com as part of your research.